I-Derm

I-DermI-Derm
I

I-Derm

I Derm Pharma is developing a first-in-class oral therapy for psoriasis and other autoimmune skin inflammatory diseases.

Website
DR 0.92022ActiveTel Aviv, Israel
Rate
Advertise here

About

I-Derm develops a new nonsteroidal topical treatment for inflammatory skin diseases based on a novel mechanism of action. This mechanism directly targets cutaneous elements rather than the immune system and is therefore uniquely function only on the skin. This novel treatment will be the first nonsteroidal topical treatments for psoriasis.
Frequently asked

What does I-Derm do?

I-Derm develops a new nonsteroidal topical treatment for inflammatory skin diseases based on a novel mechanism of action. This mechanism directly targets cutaneous elements rather than the immune system and is therefore uniquely function only on the skin. This novel treatment will be the first nonsteroidal topical treatments for psoriasis.

Where is I-Derm headquartered?

I-Derm is headquartered in Tel Aviv, Israel.

When was I-Derm founded?

I-Derm was founded in 2022.

What industry does I-Derm operate in?

I-Derm operates in Life Sciences.

Comments

No comments yet. Be the first to share your take.